Prevalance of <it>BRCA1</it> and <it>BRCA2</it> mutations in familial breast cancer patients in Lebanon

<p>Abstract</p> <p>Breast cancer is the most prevalent malignancy in women in Western countries, currently accounting for one third of all female cancers. Familial aggregation is thought to account for 5–10 % of all BC cases, and germline mutations in <it>BRCA1</it> and...

Full description

Bibliographic Details
Main Authors: Jalkh Nadine, Nassar-Slaba Jinane, Chouery Eliane, Salem Nabiha, Uhrchammer Nancy, Golmard Lisa, Stoppa-Lyonnet Domique, Bignon Yves-Jean, Mégarbané André
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
Online Access:http://www.hccpjournal.com/content/10/1/7